Global Health Technologies Coalition (GHTC)

After a busy season of multilateral convenings on #GlobalHealth, from #UNGA to #WHS, GHTC is reflecting on the insights and opportunities for the future of global health innovation emerging from crucial conversations and engagements at these fora. www.ghtcoalition.org/blog/a-seaso...

@cepi.net has launched a critical Phase 2/3 clinical trial to evaluate vaccine candidates for the #Bundibugyo strain of Ebolavirus, which is responsible for the current outbreak in the DRC and currently has no approved vaccine. www.ghtcoalition.org/blog/researc...

What's new in #GlobalHealth R&D? 💉 #Bundibugyo vaccine trial launch 🔬Male contraceptive R&D funding 🥼Needle-free mRNA vaccine method www.ghtcoalition.org/blog/researc...

What is a push mechanism vs. a pull mechanism? And how can they help advance the development of #GlobalHealth technologies? Find out in our R&D dictionary. 🌍📷🕮 www.ghtcoalition.org/global-healt...

We are so excited to welcome new GHTC member, the Male Contraceptive Initiative (MCI)! MCI is a nonprofit that provides funding and advocacy support for the R&D of novel, nonhormonal male birth control methods. Learn more! www.ghtcoalition.org/our-members/...

New research from scientists in the United Kingdom highlights a new mechanism that a dangerous fungus uses to evade antifungal treatments. www.ghtcoalition.org/blog/researc...

As countries pursue Plasmodium vivax elimination, questions remain about the role of radical cure in achieving and sustaining progress. Is radical cure essential for P. vivax elimination, or can countries achieve their goals without it? 🔗Register for this webinar: https://bit.ly/4enHQUT

Increased attention to #NTDs has fueled research breakthroughs, but significant gaps remain in the arsenal of tools needed to control and eliminate them. Learn more in our fact sheet about past successes and tools in development. 🔬🥼➡️bit.ly/3wAhvxV

An international research team has identified a crucial compound in the saliva of virus-carrying mosquitoes that could lead to a new prevention strategy for multiple mosquito-borne viruses. www.ghtcoalition.org/blog/researc...

🔬 Call for proposals: Research on Andes virus and related hantaviruses ISIDORe II offers researchers free access to European research facilities and expertise to study treatments, diagnostics and experimental models. 📅 Apply by 11 December 2026 🔗 isidore-project.eu/calls/andes-...

TAG’s 2026 Tuberculosis Vaccines Pipeline Report, by Mike Frick, is here. From long-awaited clinical trial results to a major manufacturing milestone, this year brought important developments in TB vaccine research and development.

A new study sheds light on the findings of a recent trial evaluating the ability of a laboratory-made bnAb to prevent #HIV infection, pointing to approaches that could lead to more successful future antibodies and vaccines. www.ghtcoalition.org/blog/researc...

What's new in #GlobalHealth R&D? 🥼 #HIV discovery 🦟Virus-carrying mosquito research 🧫Antifungal resistance study www.ghtcoalition.org/blog/researc...

Congrats to @mmv.org & @deepmirror.bsky.social's open-access drug discovery platform for being recognized as one of Time's Best Innovations of 2026! Also kudos to @gatesfoundation.bsky.social, whose support helped advance the OdonAssist and MiniDock MTB also recognized. time.com/collection/b...

One of TIME's Best Inventions of 2026! MMV and @deepmirror.bsky.social's AI-powered dd4gh platform is helping accelerate drug discovery for #malaria and neglected diseases while broadening access to advanced research tools for scientists in affected countries: bit.ly/4zu143h

We are so excited to welcome our newest member, the @swhr.bsky.social! The Society for Women’s Health Research is a national thought leader that has been advancing women’s health through science, policy, and education for more than 30 years. www.ghtcoalition.org/our-members/...

A Phase 1 clinical trial in Uganda just launched evaluating the safety and immune response of a vaccine candidate for #Bundibugyo, the severe strain of Ebolavirus behind the ongoing outbreak in the Democratic Republic of the Congo. www.ghtcoalition.org/blog/researc...

At #WHS, GHTC ED Kristie Mikus co-moderated an event on the tremendous impact and shifting role of PDPs in an evolving global health R&D landscape. Thanks to @mmv.org, @popcouncil.bsky.social, IVCC, @tballiance.bsky.social, @dsw-intl.bsky.social, @path.org, & @dndi.org!

Our six-part US agency fact sheet series examines the contributions of key US agencies to #GlobalHealth R&D, looking at each agency’s unique role, how it invests across health areas, and success stories of its impact. Check it out ⬇️ www.ghtcoalition.org/resources-it...

A team of researchers at the Massachusetts Institute of Technology has found a way to keep mRNA vaccines stable at higher temperatures, which could drastically lower costs and improve access to the technology in low-resource settings around the world. www.ghtcoalition.org/blog/researc...

A study from the University of California, San Francisco found that a new long-acting #HIV combination treatment could provide an alternative, more accessible option for some people with HIV. www.ghtcoalition.org/blog/researc...

Global health has no shortage of ambition. Turning it into impact takes collaboration. At @worldhealthsummit.bsky.social, MMV and partners explored how the product development partnership model can help make global health innovation more effective and sustainable.

Global health is evolving, and so are we. Today, MMV and partners published a joint paper exploring how research, innovation and product development can help build a more sovereign, resilient and equitable future for health. Read the paper: bit.ly/4enkZsr

What's new in #GlobalHealth R&D? 🥼Long-acting #HIV treatment combo 🔥Heat-stable mRNA vaccines 💉 #Bundibugyo vaccine trial www.ghtcoalition.org/blog/researc...

#AMR is steadily reducing our arsenal of tools to address deadly infections. We urgently need new #antimicrobials and antimicrobial alternatives, as well as new #diagnostics and #vaccines. Learn more about breakthrough technologies in development 🔬💉➡️bit.ly/AMR-FS

Where medicines are made impacts who can access them. Africa is heavily reliant on imports for the medicines needed to fight #malaria. MMV works with African manufacturers and Africa CDC to strengthen local production and bring medicines closer to patients. bit.ly/4zc2X4m

✈️GHTC ED Kristie Mikus is heading to Berlin for #WHS! We look forward to engaging with you all - including at a PDP-focused event w/ @mmv.org, @popcouncil.bsky.social, IVCC, @tballiance.bsky.social, @dsw-intl.bsky.social, @path.org, & @dndi.org. See more! www.worldhealthsummit.org/sessions/4f5...

US #GlobalHealth R&D investments save lives, strengthen health security, and support the US economy. When research is cut short, progress, people, and preparedness suffer. Explore these impacts in our Innovation Interrupted tool: bit.ly/3RKTkcK

A new early-stage trial assessing @ox.ac.uk's Bundibugyo ebolavirus vaccine candidate has launched in Uganda. The CEPI-funded study is being conducted by MRC/UVRI & LSHTM Uganda Research Unit with @ovg.ox.ac.uk and Pandemic Sciences Institute and the Serum Institute of India manufacturing doses.

Pleased to launch our first drug discovery partnership in Africa with KNUST. We’ll screen 100 compounds against schistosomiasis parasites, to develop the next gen of treatments while strengthening African-led drug discovery capacity. Supported by the BMFTR. www.dndi.org/press-releas...

🚨Kyle House Group & the University of Utah are cohosting a congressional event on Friday in Salt Lake City bringing together the university community and state leaders to discuss Utah’s contributions to advancing global health and development. Register here! docs.google.com/forms/d/e/1F...

What's new in #GlobalHealth R&D? 🧪Pooled #TB testing 🦟Promising #malaria drug 💊Antifungal development funding www.ghtcoalition.org/blog/researc...

Our six-part US agency fact sheet series examines the contributions of key US agencies to #GlobalHealth R&D, looking at each agency’s unique role, how it invests across health areas, and success stories of its impact. Check it out ⬇️ www.ghtcoalition.org/resources-it...

Following encouraging Phase 2a results, MMV will lead the next phase of cabamiquine's development. Long-acting cabamiquine, with potential to become a single-dose treatment or prevention option, could help address drug resistance & block transmission: bit.ly/4ypoy9x

As AI continues to rapidly transform many aspects of technology and science, including health research, a new report from @who.int speaks to how stakeholders can help ensure AI-enabled health research is conducted responsibly and benefits everyone. www.ghtcoalition.org/blog/researc...

What’s the difference between a patent pool and a pooled fund? Check out our #GlobalHealth R&D dictionary to learn more. 🌍🕮 www.ghtcoalition.org/global-healt...

As global health leaders ready themselves for this year’s World Health Summit Health Summit in Berlin, CEPI invites you to join its official panel discussion, From Crisis Response to Resilience: Innovating for Health Security Beyond Borders. Register: www.worldhealthsummit.org/sessions/034...

The first participants have been vaccinated in a trial in the DRC, where the country’s ongoing outbreak of the #Bundibugyo strain of #Ebola has now become the largest Ebola outbreak in the country’s history and the second largest in history. www.ghtcoalition.org/blog/researc...

🤝 GARDP and @dndi.org are pleased to announce support from the Foundation for the Adaptation of International Geneva to strengthen collaboration, share capabilities and resources, and help both focus more on developing and ensuring access to treatments for NTDs and drug-resistant infections.

New funding: The @bioprevail.bsky.social x CEPI Biosecurity Innovation Challenge is seeking practical biosafety and biosecurity innovations to strengthen vaccine R&D and manufacturing during epidemic and pandemic responses, supporting CEPI’s 100 Days Mission: bioprevail.org/challenge/bi...

Recent results from a trial testing a new regimen for people with chronic T. cruzi infection could offer a safer, more practical treatment option for the infection, which affects more than seven million people globally. www.ghtcoalition.org/blog/researc...

What's new in #GlobalHealth R&D? 💊Shorter #Chagas treatment regimen 💉 #Ebola vaccine trial 🖥️AI in health research report www.ghtcoalition.org/blog/researc...

Ensuring everyone globally who wishes to use contraception has access to safe, effective, and acceptable options will require a variety of new and improved contraceptive choices. Check out some tools in pipeline! #WorldContraceptionDay www.ghtcoalition.org/blog/world-c...

@cepi.net recently announced that it is awarding $3.9 million to support research projects aimed at improving understanding of the #Bundibugyo ebolavirus behind the ongoing outbreak in the Democratic Republic of the Congo. www.ghtcoalition.org/blog/researc...

US funding changes in 2025 stalled a range of promising #GlobalHealth R&D efforts, disrupting ongoing work to advance critical innovations across the United States and worldwide. Explore these impacts in our Innovation Interrupted tool. bit.ly/3RKTkcK

At #UNGA80 ahead of the PPPR HLM, our conversations reinforced a key message: pandemic preparedness & innovation go hand in hand. A discussion we hosted with Adjuvant Capital, State Dept officials, & partners explored the systems, technologies, & partnerships needed to strengthen preparedness.

@who.int has updated its malaria guidelines to include Coartem Baby, the first antimalarial developed specifically for newborns and young infants weighing between two and five kilograms, a group that previously had no medicine specifically designed for them. www.ghtcoalition.org/blog/researc...

Last week, Gilead announced that it has expanded its voluntary licensing agreements with partners, who are already manufacturing the recently approved twice-yearly #lenacapavir for #HIV prevention, to include investigational once-yearly lenacapavir. www.ghtcoalition.org/blog/researc...

🔉 Major new funding for CEPI announced today. Ethiopia, Norway and the UK have pledged a combined US$240 million to support CEPI’s five-year plan to transform the world’s ability to prevent and respond to future epidemic and pandemic threats. cepi.net/ethiopia-nor...

What's new in #GlobalHealth R&D? 💉Investigational once-yearly #HIV prevention planning 💊Newborn #malaria drug rollout 🥼#Bundibugyo Ebola research t.co/piZZWvhcII